₹313
(Inclusive of all Taxes)
₹47.0 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
తయారీదారు/మార్కెటర్ :
Cachet Pharmaceuticals Pvt Ltd
వినియోగ రకం :
నోటి ద్వారా
రిటర్న్ పాలసీ :
తిరిగి ఇవ్వబడదు
వీటి తర్వాత లేదా తర్వాత గడువు ముగుస్తుంది :
Jan-27
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Myospas D Tablet:
Co-administration of Myospas D Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Myospas D Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Co-administration of Myospas D Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Myospas D Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Severe
How does the drug interact with Myospas D Tablet:
Co-administration of Myospas D Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Myospas D Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Myospas D Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Myospas D Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
How does the drug interact with Myospas D Tablet:
Co-administration of Myospas D Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
Co-administration of Myospas D Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
DiclofenacMipomersen
Severe
How does the drug interact with Myospas D Tablet:
Co-administration of Myospas D Tablet with Mipomersen may cause liver problems.
How to manage the interaction:
Co-administration of Myospas D Tablet and Mipomersen can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of hunger, fatigue, nausea, vomiting, abdominal pain, dark urine, pale stools, and/or yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
Co-administration of Myospas D Tablet with Mipomersen may cause liver problems.
How to manage the interaction:
Co-administration of Myospas D Tablet and Mipomersen can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of hunger, fatigue, nausea, vomiting, abdominal pain, dark urine, pale stools, and/or yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Myospas D Tablet:
Taking Myospas D Tablet and ibuprofen can increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Co-administration of Myospas D Tablet and Ibuprofen can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Myospas D Tablet and ibuprofen can increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Co-administration of Myospas D Tablet and Ibuprofen can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Myospas D Tablet:
Taking Myospas D Tablet with Panobinostat can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Panobinostat, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or have other signs of bleeding like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.
Taking Myospas D Tablet with Panobinostat can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Panobinostat, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or have other signs of bleeding like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.
Severe
How does the drug interact with Myospas D Tablet:
Co-administration of Rivaroxaban together with Myospas D Tablet may increase the risk of unsual bleeding.
How to manage the interaction:
Co-administration of Myospas D Tablet and Rivaroxaban can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Rivaroxaban together with Myospas D Tablet may increase the risk of unsual bleeding.
How to manage the interaction:
Co-administration of Myospas D Tablet and Rivaroxaban can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Myospas D Tablet:
Coadministration of Myospas D Tablet with Ketoconazole may increase the risk of liver problems.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Ketoconazole, but they can be taken together if a doctor has prescribed them. However, consult a doctor immediately if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
Coadministration of Myospas D Tablet with Ketoconazole may increase the risk of liver problems.
How to manage the interaction:
There may be a possible interaction between Myospas D Tablet and Ketoconazole, but they can be taken together if a doctor has prescribed them. However, consult a doctor immediately if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Myospas D Tablet:
Co administration of Myospas D Tablet with Leflunomide may result in liver problems.
How to manage the interaction:
Co-administration of Myospas D Tablet and Leflunomide can lead to an interaction; it can be taken if advised by your doctor. However, if you have a fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, or yellowing of the skin or eyes. Do not stop using any medication without consulting your doctor.
Co administration of Myospas D Tablet with Leflunomide may result in liver problems.
How to manage the interaction:
Co-administration of Myospas D Tablet and Leflunomide can lead to an interaction; it can be taken if advised by your doctor. However, if you have a fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, or yellowing of the skin or eyes. Do not stop using any medication without consulting your doctor.
How does the drug interact with Myospas D Tablet:
Concomitant use of Myospas D Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Myospas D Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Concomitant use of Myospas D Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Myospas D Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
మద్యం
సురక్షితం కాదు
Myospas D Tablet 10's తీసుకునేటప్పుడు మద్యం సేవించడం మానుకోండి ఎందుకంటే ఇది మగతను పరిమాణాన్ని పెంచుస్తుంది. ఇది కడుపు రక్తస్రావం ప్రమాదాన్ని కూడా పెంచుతుంది.
గర్భధారణ
జాగ్రత్త
దీని గురించి మీకు ఏవైనా సందేహాలు ఉంటే దయ favorsు మీ వైద్యుడిని సంప్రదించండి; ప్రయోజనాలు నష్టాల కంటే ఎక్కువగా ఉంటేనే మీ వైద్యుడు సూచిస్తారు.
తల్లి పాలు ఇవ్వడం
జాగ్రత్త
Myospas D Tablet 10's తీసుకునే ముందు మీ వైద్యుడిని సంప్రదించండి; తల్లి పాలు ఇచ్చే తల్లులు Myospas D Tablet 10's తీసుకోవచ్చా లేదా అనే దానిపై మీ వైద్యుడు నిర్ణయిస్తారు.
డ్రైవింగ్
జాగ్రత్త
Myospas D Tablet 10's మగతకు కారణం కావచ్చు. మీరు అప్రమత్తంగా లేకుంటే వాహనాలు నడపవద్దు లేదా యంత్రాలను నడపవద్దు.
లివర్
జాగ్రత్త
కాలిజం బలహీనత ఉన్న రోగులలో మోతాదు సర్దుబాటు అవసరం కావచ్చు. మీకు లివర్ బలహీనత లేదా దీని గురించి ఏవైనా సందేహాలు ఉంటే దయ favorsు మీ వైద్యుడిని సంప్రదించండి.
కిడ్నీ
జాగ్రత్త
కిడ్నీ బలహీనత ఉన్న రోగులలో మోతాదు సర్దుబాటు అవసరం కావచ్చు. మీకు కిడ్నీ బలహీనత లేదా దీని గురించి ఏవైనా సందేహాలు ఉంటే దయ favorsు మీ వైద్యుడిని సంప్రదించండి.
పిల్లలు
సురక్షితం కాదు
భద్రత మరియు ప్రభావాన్ని నిర్ధారించనందున పిల్లలకు Myospas D Tablet 10's ఇవ్వకూడదు.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
